Home > Insider Trading > Filing (0000914190-16-000740)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1195116	Arno Therapeutics Inc	ARNI	Pharmaceutical Preparations (2834)	522286452

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1568077	Tomer Kariv	200 Route 31 North Suite 104 Flemington NJ 08822		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-15	349,168	$0.00	1,696,495	No	4	P	Indirect	By Pontifax (Cayman) II L.P.
Common Stock	Acquisiton	2016-08-15	263,017	$0.00	1,277,905	No	4	P	Indirect	By Pontifax (Israel) II L.P.
Common Stock	Acquisiton	2016-08-15	102,100	$0.00	496,068	No	4	P	Indirect	By Pontifax (Israel) II - Individual Investors L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Pontifax (Cayman) II L.P.
No	4	P	Indirect	By Pontifax (Israel) II L.P.
No	4	P	Indirect	By Pontifax (Israel) II - Individual Investors L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2016 Series F Warrants (right to buy)	Acquisiton	2016-08-15	174,584	$0.00	174,584	$0.44
Common Stock	2016 Series F Warrants (right to buy)	Acquisiton	2016-08-15	131,508	$0.00	131,508	$0.44
Common Stock	2016 Series F Warrants (right to buy)	Acquisiton	2016-08-15	51,050	$0.00	51,050	$0.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
174,584	2016-08-16	2021-08-16	No	4	P	Indirect
131,508	2016-08-15	2021-08-15	No	4	P	Indirect
51,050	2016-08-15	2021-08-16	No	4	P	Indirect

Footnotes

The reported securities are included within 349,168 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The reported securities are included within 263,017 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
The reported securities are included within 102,100 Issuer units committed to purchase by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.